Your browser doesn't support javascript.
loading
Diminazene aceturate uses different pathways to induce relaxation in healthy and atherogenic blood vessels.
Kate Gadanec, Laura; Qaradakhi, Tawar; Renee McSweeney, Kristen; Matsoukas, John M; Apostolopoulos, Vasso; Burrell, Louise M; Zulli, Anthony.
Afiliação
  • Kate Gadanec L; Institute for Health and Sport, Victoria University, Melbourne 3030, Victoria, Australia. Electronic address: laura.gadanec@live.vu.edu.au.
  • Qaradakhi T; Institute for Health and Sport, Victoria University, Melbourne 3030, Victoria, Australia. Electronic address: taqar.qaradakhi@live.vu.edu.au.
  • Renee McSweeney K; Institute for Health and Sport, Victoria University, Melbourne 3030, Victoria, Australia. Electronic address: kristen.mcsweeney@live.vu.edu.au.
  • Matsoukas JM; Institute for Health and Sport, Victoria University, Melbourne 3030, Victoria, Australia; Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Alberta T2N 4N1, Canada; NewDrug PC, Patras Science Park, 26500 Patras, Greece. Electronic address: imats1953@gmail.
  • Apostolopoulos V; Institute for Health and Sport, Victoria University, Melbourne 3030, Victoria, Australia; Australian Institute for Musculoskeletal Science, Melbourne 3021, Victoria, Australia. Electronic address: vasso.apostolopoulos@vu.edu.au.
  • Burrell LM; Department of Medicine, Austin Health, University of Melbourne, Heidelberg 3084, Victoria, Australia. Electronic address: l.burrell@unimelb.edu.au.
  • Zulli A; Institute for Health and Sport, Victoria University, Melbourne 3030, Victoria, Australia. Electronic address: anthony.zulli@vu.edu.au.
Biochem Pharmacol ; 208: 115397, 2023 02.
Article em En | MEDLINE | ID: mdl-36566945

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptidil Dipeptidase A / Aterosclerose Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptidil Dipeptidase A / Aterosclerose Idioma: En Ano de publicação: 2023 Tipo de documento: Article